Industry Research Reports
Home > Reports > Chemical & Material > Global Pharmaceutical Active and Intelligent Packaging Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pharmaceutical Active and Intelligent Packaging Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-03
Pages: 145 Pages
Report ld: 5104367
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Active and Intelligent Packaging Market Size(US$)
CAGR 2025-2031
9.0%
Market Size,2031
USD 111,390
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 66,420 million
Market Forecast in 2031(Value)
US$ 111,390 million
CAGR
9.0%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Active and Intelligent Packaging market is projected to grow from US$ 61440 million in 2024 to US$ 111390 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pharmaceutical Active and Intelligent Packaging market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- BASF
- Amcor
- Honeywell International
- Landec
- Bemis Company
- Crown Holdings
- Ball Corporation
- Sonoco Products
- Graphic Packaging
- Timestrip UK
- Coveris Holdings
- Sealed Air Corporation
- Dessicare
- WestRock Company
- CCL Industrie
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Active Packaging
- Intelligent Packaging
Segment by Application
- Human Medicine
- Veterinary Medicine
CHAPTER OUTLINE
Chapter 1: Defines the Pharmaceutical Active and Intelligent Packaging study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pharmaceutical Active and Intelligent Packaging: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Active and Intelligent Packaging Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Active Packaging
1.2.3 Intelligent Packaging
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Active and Intelligent Packaging Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Human Medicine
1.3.3 Veterinary Medicine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Active and Intelligent Packaging Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Active and Intelligent Packaging Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmaceutical Active and Intelligent Packaging Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmaceutical Active and Intelligent Packaging Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Active Packaging Market Size by Players
3.3.2 Intelligent Packaging Market Size by Players
3.4 Global Pharmaceutical Active and Intelligent Packaging Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Active and Intelligent Packaging Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Active and Intelligent Packaging Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2031)
6.4 North America Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Active and Intelligent Packaging Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2031)
7.4 Europe Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Active and Intelligent Packaging Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmaceutical Active and Intelligent Packaging Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2031)
9.4 Central and South America Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Active and Intelligent Packaging Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Active and Intelligent Packaging Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Active and Intelligent Packaging Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Active and Intelligent Packaging Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BASF
11.1.1 BASF Corporation Information
11.1.2 BASF Business Overview
11.1.3 BASF Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.1.4 BASF Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.1.5 BASF Pharmaceutical Active and Intelligent Packaging Revenue by Product in 2024
11.1.6 BASF Pharmaceutical Active and Intelligent Packaging Revenue by Application in 2024
11.1.7 BASF Pharmaceutical Active and Intelligent Packaging Revenue by Geographic Area in 2024
11.1.8 BASF Pharmaceutical Active and Intelligent Packaging SWOT Analysis
11.1.9 BASF Recent Developments
11.2 Amcor
11.2.1 Amcor Corporation Information
11.2.2 Amcor Business Overview
11.2.3 Amcor Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.2.4 Amcor Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.2.5 Amcor Pharmaceutical Active and Intelligent Packaging Revenue by Product in 2024
11.2.6 Amcor Pharmaceutical Active and Intelligent Packaging Revenue by Application in 2024
11.2.7 Amcor Pharmaceutical Active and Intelligent Packaging Revenue by Geographic Area in 2024
11.2.8 Amcor Pharmaceutical Active and Intelligent Packaging SWOT Analysis
11.2.9 Amcor Recent Developments
11.3 Honeywell International
11.3.1 Honeywell International Corporation Information
11.3.2 Honeywell International Business Overview
11.3.3 Honeywell International Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.3.4 Honeywell International Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.3.5 Honeywell International Pharmaceutical Active and Intelligent Packaging Revenue by Product in 2024
11.3.6 Honeywell International Pharmaceutical Active and Intelligent Packaging Revenue by Application in 2024
11.3.7 Honeywell International Pharmaceutical Active and Intelligent Packaging Revenue by Geographic Area in 2024
11.3.8 Honeywell International Pharmaceutical Active and Intelligent Packaging SWOT Analysis
11.3.9 Honeywell International Recent Developments
11.4 Landec
11.4.1 Landec Corporation Information
11.4.2 Landec Business Overview
11.4.3 Landec Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.4.4 Landec Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.4.5 Landec Pharmaceutical Active and Intelligent Packaging Revenue by Product in 2024
11.4.6 Landec Pharmaceutical Active and Intelligent Packaging Revenue by Application in 2024
11.4.7 Landec Pharmaceutical Active and Intelligent Packaging Revenue by Geographic Area in 2024
11.4.8 Landec Pharmaceutical Active and Intelligent Packaging SWOT Analysis
11.4.9 Landec Recent Developments
11.5 Bemis Company
11.5.1 Bemis Company Corporation Information
11.5.2 Bemis Company Business Overview
11.5.3 Bemis Company Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.5.4 Bemis Company Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.5.5 Bemis Company Pharmaceutical Active and Intelligent Packaging Revenue by Product in 2024
11.5.6 Bemis Company Pharmaceutical Active and Intelligent Packaging Revenue by Application in 2024
11.5.7 Bemis Company Pharmaceutical Active and Intelligent Packaging Revenue by Geographic Area in 2024
11.5.8 Bemis Company Pharmaceutical Active and Intelligent Packaging SWOT Analysis
11.5.9 Bemis Company Recent Developments
11.6 Crown Holdings
11.6.1 Crown Holdings Corporation Information
11.6.2 Crown Holdings Business Overview
11.6.3 Crown Holdings Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.6.4 Crown Holdings Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.6.5 Crown Holdings Recent Developments
11.7 Ball Corporation
11.7.1 Ball Corporation Corporation Information
11.7.2 Ball Corporation Business Overview
11.7.3 Ball Corporation Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.7.4 Ball Corporation Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.7.5 Ball Corporation Recent Developments
11.8 Sonoco Products
11.8.1 Sonoco Products Corporation Information
11.8.2 Sonoco Products Business Overview
11.8.3 Sonoco Products Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.8.4 Sonoco Products Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.8.5 Sonoco Products Recent Developments
11.9 Graphic Packaging
11.9.1 Graphic Packaging Corporation Information
11.9.2 Graphic Packaging Business Overview
11.9.3 Graphic Packaging Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.9.4 Graphic Packaging Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.9.5 Graphic Packaging Recent Developments
11.10 Timestrip UK
11.10.1 Timestrip UK Corporation Information
11.10.2 Timestrip UK Business Overview
11.10.3 Timestrip UK Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.10.4 Timestrip UK Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Coveris Holdings
11.11.1 Coveris Holdings Corporation Information
11.11.2 Coveris Holdings Business Overview
11.11.3 Coveris Holdings Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.11.4 Coveris Holdings Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.11.5 Coveris Holdings Recent Developments
11.12 Sealed Air Corporation
11.12.1 Sealed Air Corporation Corporation Information
11.12.2 Sealed Air Corporation Business Overview
11.12.3 Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.12.4 Sealed Air Corporation Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.12.5 Sealed Air Corporation Recent Developments
11.13 Dessicare
11.13.1 Dessicare Corporation Information
11.13.2 Dessicare Business Overview
11.13.3 Dessicare Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.13.4 Dessicare Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.13.5 Dessicare Recent Developments
11.14 WestRock Company
11.14.1 WestRock Company Corporation Information
11.14.2 WestRock Company Business Overview
11.14.3 WestRock Company Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.14.4 WestRock Company Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.14.5 WestRock Company Recent Developments
11.15 CCL Industrie
11.15.1 CCL Industrie Corporation Information
11.15.2 CCL Industrie Business Overview
11.15.3 CCL Industrie Pharmaceutical Active and Intelligent Packaging Product Features and Attributes
11.15.4 CCL Industrie Pharmaceutical Active and Intelligent Packaging Revenue and Gross Margin (2020-2025)
11.15.5 CCL Industrie Recent Developments
12 Pharmaceutical Active and Intelligent PackagingIndustry Chain Analysis
12.1 Pharmaceutical Active and Intelligent Packaging Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Active and Intelligent Packaging Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Active and Intelligent Packaging Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Active and Intelligent Packaging Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Active and Intelligent Packaging Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Active and Intelligent Packaging Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Active and Intelligent Packaging Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Active and Intelligent Packaging Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Pharmaceutical Active and Intelligent Packaging Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Pharmaceutical Active and Intelligent Packaging by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Active and Intelligent Packaging as of 2024)
Table 11. Global Pharmaceutical Active and Intelligent Packaging Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Pharmaceutical Active and Intelligent Packaging Companies Headquarters
Table 13. Global Pharmaceutical Active and Intelligent Packaging Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Pharmaceutical Active and Intelligent Packaging Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Pharmaceutical Active and Intelligent Packaging Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Pharmaceutical Active and Intelligent Packaging Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Pharmaceutical Active and Intelligent Packaging Revenue by Application (2026-2031) & (US$ Million)
Table 21. Pharmaceutical Active and Intelligent Packaging High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Pharmaceutical Active and Intelligent Packaging Growth Accelerators and Market Barriers
Table 25. North America Pharmaceutical Active and Intelligent Packaging Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Pharmaceutical Active and Intelligent Packaging Growth Accelerators and Market Barriers
Table 27. Europe Pharmaceutical Active and Intelligent Packaging Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Pharmaceutical Active and Intelligent Packaging Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Pharmaceutical Active and Intelligent Packaging Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Pharmaceutical Active and Intelligent Packaging Investment Opportunities and Key Challenges
Table 31. Central and South America Pharmaceutical Active and Intelligent Packaging Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Pharmaceutical Active and Intelligent Packaging Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Pharmaceutical Active and Intelligent Packaging Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. BASF Corporation Information
Table 35. BASF Description and Major Businesses
Table 36. BASF Product Features and Attributes
Table 37. BASF Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. BASF Revenue Proportion by Product in 2024
Table 39. BASF Revenue Proportion by Application in 2024
Table 40. BASF Revenue Proportion by Geographic Area in 2024
Table 41. BASF Pharmaceutical Active and Intelligent Packaging SWOT Analysis
Table 42. BASF Recent Developments
Table 43. Amcor Corporation Information
Table 44. Amcor Description and Major Businesses
Table 45. Amcor Product Features and Attributes
Table 46. Amcor Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Amcor Revenue Proportion by Product in 2024
Table 48. Amcor Revenue Proportion by Application in 2024
Table 49. Amcor Revenue Proportion by Geographic Area in 2024
Table 50. Amcor Pharmaceutical Active and Intelligent Packaging SWOT Analysis
Table 51. Amcor Recent Developments
Table 52. Honeywell International Corporation Information
Table 53. Honeywell International Description and Major Businesses
Table 54. Honeywell International Product Features and Attributes
Table 55. Honeywell International Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Honeywell International Revenue Proportion by Product in 2024
Table 57. Honeywell International Revenue Proportion by Application in 2024
Table 58. Honeywell International Revenue Proportion by Geographic Area in 2024
Table 59. Honeywell International Pharmaceutical Active and Intelligent Packaging SWOT Analysis
Table 60. Honeywell International Recent Developments
Table 61. Landec Corporation Information
Table 62. Landec Description and Major Businesses
Table 63. Landec Product Features and Attributes
Table 64. Landec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Landec Revenue Proportion by Product in 2024
Table 66. Landec Revenue Proportion by Application in 2024
Table 67. Landec Revenue Proportion by Geographic Area in 2024
Table 68. Landec Pharmaceutical Active and Intelligent Packaging SWOT Analysis
Table 69. Landec Recent Developments
Table 70. Bemis Company Corporation Information
Table 71. Bemis Company Description and Major Businesses
Table 72. Bemis Company Product Features and Attributes
Table 73. Bemis Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Bemis Company Revenue Proportion by Product in 2024
Table 75. Bemis Company Revenue Proportion by Application in 2024
Table 76. Bemis Company Revenue Proportion by Geographic Area in 2024
Table 77. Bemis Company Pharmaceutical Active and Intelligent Packaging SWOT Analysis
Table 78. Bemis Company Recent Developments
Table 79. Crown Holdings Corporation Information
Table 80. Crown Holdings Description and Major Businesses
Table 81. Crown Holdings Product Features and Attributes
Table 82. Crown Holdings Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Crown Holdings Recent Developments
Table 84. Ball Corporation Corporation Information
Table 85. Ball Corporation Description and Major Businesses
Table 86. Ball Corporation Product Features and Attributes
Table 87. Ball Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Ball Corporation Recent Developments
Table 89. Sonoco Products Corporation Information
Table 90. Sonoco Products Description and Major Businesses
Table 91. Sonoco Products Product Features and Attributes
Table 92. Sonoco Products Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Sonoco Products Recent Developments
Table 94. Graphic Packaging Corporation Information
Table 95. Graphic Packaging Description and Major Businesses
Table 96. Graphic Packaging Product Features and Attributes
Table 97. Graphic Packaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Graphic Packaging Recent Developments
Table 99. Timestrip UK Corporation Information
Table 100. Timestrip UK Description and Major Businesses
Table 101. Timestrip UK Product Features and Attributes
Table 102. Timestrip UK Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Timestrip UK Recent Developments
Table 104. Coveris Holdings Corporation Information
Table 105. Coveris Holdings Description and Major Businesses
Table 106. Coveris Holdings Product Features and Attributes
Table 107. Coveris Holdings Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Coveris Holdings Recent Developments
Table 109. Sealed Air Corporation Corporation Information
Table 110. Sealed Air Corporation Description and Major Businesses
Table 111. Sealed Air Corporation Product Features and Attributes
Table 112. Sealed Air Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Sealed Air Corporation Recent Developments
Table 114. Dessicare Corporation Information
Table 115. Dessicare Description and Major Businesses
Table 116. Dessicare Product Features and Attributes
Table 117. Dessicare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Dessicare Recent Developments
Table 119. WestRock Company Corporation Information
Table 120. WestRock Company Description and Major Businesses
Table 121. WestRock Company Product Features and Attributes
Table 122. WestRock Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. WestRock Company Recent Developments
Table 124. CCL Industrie Corporation Information
Table 125. CCL Industrie Description and Major Businesses
Table 126. CCL Industrie Product Features and Attributes
Table 127. CCL Industrie Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. CCL Industrie Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Active and Intelligent Packaging Product Picture
Figure 2. Global Pharmaceutical Active and Intelligent Packaging Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Active Packaging Product Picture
Figure 4. Intelligent Packaging Product Picture
Figure 5. Global Pharmaceutical Active and Intelligent Packaging Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Human Medicine
Figure 7. Veterinary Medicine
Figure 8. Pharmaceutical Active and Intelligent Packaging Report Years Considered
Figure 9. Global Pharmaceutical Active and Intelligent Packaging Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 11. Global Pharmaceutical Active and Intelligent Packaging Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Region (2020-2031)
Figure 13. Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Active Packaging Revenue Market Share by Player in 2024
Figure 16. Intelligent Packaging Revenue Market Share by Player in 2024
Figure 17. Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Type (2020-2031)
Figure 18. Global Pharmaceutical Active and Intelligent Packaging Revenue Market Share by Application (2020-2031)
Figure 19. North America Pharmaceutical Active and Intelligent Packaging Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) in 2024
Figure 21. North America Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Pharmaceutical Active and Intelligent Packaging Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) in 2024
Figure 28. Europe Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 31. France Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Pharmaceutical Active and Intelligent Packaging Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 43. India Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Pharmaceutical Active and Intelligent Packaging Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Pharmaceutical Active and Intelligent Packaging Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) in 2024
Figure 51. Central and South America Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Pharmaceutical Active and Intelligent Packaging Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Pharmaceutical Active and Intelligent Packaging Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Pharmaceutical Active and Intelligent Packaging Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) in 2024
Figure 57. South America Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Pharmaceutical Active and Intelligent Packaging Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Pharmaceutical Active and Intelligent Packaging Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Pharmaceutical Active and Intelligent Packaging Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Pharmaceutical Active and Intelligent Packaging Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Pharmaceutical Active and Intelligent Packaging Revenue (2020-2025) & (US$ Million)
Figure 63. Pharmaceutical Active and Intelligent Packaging Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Pharmaceutical Active and Intelligent Packaging in 2031?
The global market size of Pharmaceutical Active and Intelligent Packaging in 2031 was 111390 Million USD.
Which companies rank high in the global Pharmaceutical Active and Intelligent Packaging market?
What is the annual compound growth rate of the global Pharmaceutical Active and Intelligent Packaging market size from 2025 to 2031?
What was the global market size of Pharmaceutical Active and Intelligent Packaging in 2025?
Which region is expected to have the highest market share?
Related Reports
Pharmaceutical Active and Intelligent Packaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Active and Intelligent Packaging was estimated to be worth US$ 66420 million in 2025 and is projected to reach US$ 120420 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 106
USD 3950.00
(Single User License)
Global Pharmaceutical Active and Intelligent Packaging Market Research Report 2026
The global Pharmaceutical Active and Intelligent Packaging market was valued at US$ 66420 million in 2025 and is anticipated to reach US$ 120420 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 117
USD 2900.00
(Single User License)
Pharmaceutical Active and Intelligent Packaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Active and Intelligent Packaging was estimated to be worth US$ 61440 million in 2024 and is forecast to a readjusted size of US$ 111390 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 116
USD 3950.00
(Single User License)
Global Pharmaceutical Active and Intelligent Packaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Active and Intelligent Packaging market size was US$ 61440 million in 2024 and is forecast to a readjusted size of US$ 111390 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 4250.00
(Single User License)
Global Pharmaceutical Active and Intelligent Packaging Market Research Report 2025
The global market for Pharmaceutical Active and Intelligent Packaging was valued at US$ 61440 million in the year 2024 and is projected to reach a revised size of US$ 111390 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published Date: 2025-02-14
Pages: 86
USD 2900.00
(Single User License)
Global Pharmaceutical Active and Intelligent Packaging Market Insights, Forecast to 2030
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published Date: 2024-04-11
Pages: 117
USD 4900.00
(Single User License)
Global Pharmaceutical Active and Intelligent Packaging Market Research Report 2024
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published Date: 2024-02-21
Pages: 91
USD 2900.00
(Single User License)
Pharmaceutical Active and Intelligent Packaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published Date: 2024-01-04
Pages: 125
USD 3950.00
(Single User License)
Pharmaceutical Active and Intelligent Packaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Active and Intelligent Packaging was estimated to be worth US$ 66420 million in 2025 and is projected to reach US$ 120420 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-02-01
Pages: 106
USD 3950.00 (Single User License)Global Pharmaceutical Active and Intelligent Packaging Market Research Report 2026
The global Pharmaceutical Active and Intelligent Packaging market was valued at US$ 66420 million in 2025 and is anticipated to reach US$ 120420 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-02-01
Pages: 117
USD 2900.00 (Single User License)Pharmaceutical Active and Intelligent Packaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Active and Intelligent Packaging was estimated to be worth US$ 61440 million in 2024 and is forecast to a readjusted size of US$ 111390 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 116
USD 3950.00 (Single User License)Global Pharmaceutical Active and Intelligent Packaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Active and Intelligent Packaging market size was US$ 61440 million in 2024 and is forecast to a readjusted size of US$ 111390 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
USD 4250.00 (Single User License)Global Pharmaceutical Active and Intelligent Packaging Market Research Report 2025
The global market for Pharmaceutical Active and Intelligent Packaging was valued at US$ 61440 million in the year 2024 and is projected to reach a revised size of US$ 111390 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published: 2025-02-14
Pages: 86
USD 2900.00 (Single User License)Global Pharmaceutical Active and Intelligent Packaging Market Insights, Forecast to 2030
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published: 2024-04-11
Pages: 117
USD 4900.00 (Single User License)Global Pharmaceutical Active and Intelligent Packaging Market Research Report 2024
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published: 2024-02-21
Pages: 91
USD 2900.00 (Single User License)Pharmaceutical Active and Intelligent Packaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Refers to the packaging that can detect changes in the environment of the drug and prolong the activity of the drug
Published: 2024-01-04
Pages: 125
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now